GDTC
GDTC
NASDAQ · Biotechnology

Cytomed Therapeutics Ltd

$1.00
-0.03 (-2.91%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,331.0% upside
Low Target $15.00
Average Target $24.31
High Target $29.94
Current Price $1.00
Current
$1.00
Target
$24.31
$15.00 $24.31 avg $29.94
Scenario Analysis
Bear Case
$15.00
1,400.0%
Low target
Base Case
$24.31
+2,331.0%
Avg target
Bull Case
$29.94
+2,894.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.68
-72.8% from high
52-Week Low
$0.73
+37.3% from low
Target vs 52W High
$24.31
+560.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%